Rubicon Organics Inc. (ROMJ.V)
CAD 0.47
(-4.08%)
CAD 0.47
(-4.08%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 16.99 Million CAD | -4.37% |
| 2022 | 17.77 Million CAD | 11.49% |
| 2021 | 15.94 Million CAD | -28.29% |
| 2020 | 22.23 Million CAD | 4.56% |
| 2019 | 21.26 Million CAD | 239.23% |
| 2018 | 6.26 Million CAD | 19.83% |
| 2017 | 5.23 Million CAD | 413.76% |
| 2016 | 1.01 Million CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 19.32 Million CAD | 15.05% |
| 2024 Q1 | 16.79 Million CAD | -1.18% |
| 2023 Q3 | 17.43 Million CAD | -3.36% |
| 2023 Q4 | 16.99 Million CAD | -2.51% |
| 2023 FY | 16.99 Million CAD | -4.37% |
| 2023 Q2 | 18.04 Million CAD | 7.79% |
| 2023 Q1 | 16.73 Million CAD | -5.84% |
| 2022 Q2 | 16.04 Million CAD | 3.73% |
| 2022 Q1 | 15.46 Million CAD | -2.99% |
| 2022 Q4 | 17.77 Million CAD | 5.86% |
| 2022 Q3 | 16.79 Million CAD | 4.67% |
| 2022 FY | 17.77 Million CAD | 11.49% |
| 2021 FY | 15.94 Million CAD | -28.29% |
| 2021 Q4 | 15.94 Million CAD | -0.64% |
| 2021 Q3 | 16.04 Million CAD | 12.79% |
| 2021 Q2 | 14.22 Million CAD | -13.33% |
| 2021 Q1 | 16.41 Million CAD | -26.17% |
| 2020 Q4 | 22.23 Million CAD | 11.64% |
| 2020 Q3 | 19.91 Million CAD | 8.77% |
| 2020 Q2 | 18.3 Million CAD | -31.37% |
| 2020 FY | 22.23 Million CAD | 4.56% |
| 2020 Q1 | 26.67 Million CAD | 25.46% |
| 2019 Q1 | 9.7 Million CAD | 54.89% |
| 2019 FY | 21.26 Million CAD | 239.23% |
| 2019 Q4 | 21.26 Million CAD | 28.16% |
| 2019 Q3 | 16.58 Million CAD | 7.82% |
| 2019 Q2 | 15.38 Million CAD | 58.5% |
| 2018 Q4 | 6.26 Million CAD | -1.42% |
| 2018 FY | 6.26 Million CAD | 19.83% |
| 2018 Q3 | 6.35 Million CAD | 0.0% |
| 2017 FY | 5.23 Million CAD | 413.76% |
| 2017 Q4 | 5.23 Million CAD | 0.0% |
| 2016 FY | 1.01 Million CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.38 Million CAD | -215.92% |
| CanadaBis Capital Inc. | 15.61 Million CAD | -8.822% |
| Decibel Cannabis Company Inc. | 96.79 Million CAD | 82.44% |
| Delivra Health Brands Inc. | 4.85 Million CAD | -249.871% |
| Entourage Health Corp. | 178.68 Million CAD | 90.488% |
| Lifeist Wellness Inc. | 9.94 Million CAD | -70.982% |
| Cannara Biotech Inc. | 61.77 Million CAD | 72.488% |
| Medicure Inc. | 8.16 Million CAD | -108.217% |
| PharmaCielo Ltd. | 23.96 Million CAD | 29.089% |
| BioSyent Inc. | 6.76 Million CAD | -151.09% |
| Voyageur Pharmaceuticals Ltd. | 727.87 Thousand CAD | -2235.109% |